Replies to post #12537 on Ayala Pharmaceuticals Inc (fka ADXS)

[ignatiusrielly35]

With all due respect, FBG, the clinical development program IS the business plan. The share price is the result of a concerted manipulation scheme enabled by a still weak biotech market, and nothing else.